Health ❯ Healthcare ❯ Medical Research

Cancer Treatment

Immunotherapy Pancreatic Cancer mRNA Vaccines Breast Cancer Prostate Cancer Glioblastoma Melanoma Clinical Trials Colorectal Cancer Lung Cancer

Adelaide Team Wins $240,000 to Rework How Radiotherapy Targets Brain Tumours

Precise new DNA‑damage measurement tools aim to reveal how tuning radiotherapy could increase tumour kill and reduce harm to healthy brain tissue.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

DR5–Lig3 Feedback Loop Explains Why MSI Colorectal Tumors Respond to Immunotherapy

Selected Lung Transplants Linked to Higher One-Year Survival in Stage 4 Lung Cancer

Low-Frequency Ultrasound Selectively Kills Oral Cancer Cells

Experimental UCalgary CAR T Therapy GCAR1 Shrinks Rare Solid Tumours

CAR‑T Cells Targeting GPNMB Eradicate Glioblastoma in Preclinical Models

Fibroblasts Explain Why Lung Cancer Subtypes Respond Differently to Anti‑Angiogenic Drugs

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

U.S. Biotech Reports Major Survival Gain in Pancreatic Cancer as Hiroshima Plans 2028 Trial for MicroRNA Mesothelioma Drug

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

UC Study Links Some Antibody‑Drug Conjugates to High Rates of Severe Neutropenia

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Amivantamab Injection Eradicates Tumours in Treatment‑Resistant Head and Neck Cancer Trial